榴莲视频

In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose

Ophthalmologists say findings emphasize the importance of adhering to medication regimens

Delegates express concerns that PPE doesn't always cover women, who are more at risk of exposure

Peter K. Kaiser, MD, leads a discussion about the presentation given by Yasha S. Modi, MD, at AAO

Members also debate alternative ways states can safely license foreign med-school graduates

Ophthalmologists hope expanded use will lead to more evaluations in primary clinics

Valeda photobiomodulation system slowed disease progression and improved vision

Peter K. Kaiser, MD, leads a discussion from the AAO meeting

Retired physician Jay Berger, MD, reportedly suffered a mental health crisis

Provision in drug act would prohibit repackaging Avastin, add millions to anti-VEGF therapy cost

Significant improvement beyond 100 weeks after single injection of mutation-agnostic MCO-010

Office procedure reduced visual field loss by 29% over 6 years versus eye drops

Three cycles could become the new standard for retinoblastoma, researchers say

Drug targeting junctional zone reduces GA growth by 48% in 3 months, oral agent moderately active